KalVista Pharmaceuticals (KALV) Reports Q2 Loss of $0.22/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q2 EPS of ($0.22), versus ($0.50) reported last year. Revenue for the quarter came in at $5.59 million, versus $1.13 million reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs